Publicacións nas que colabora con Yolanda Pazos Randulfe (8)

2022

  1. Concurrent Akt, ERK1/2 and AMPK Activation by Obestatin Inhibits Apoptotic Signaling Cascades on Nutrient-Deprived PC12 Cells

    Cellular and Molecular Neurobiology, Vol. 42, Núm. 5, pp. 1607-1614

2021

  1. Obestatin signalling counteracts glucocorticoid-induced skeletal muscle atrophy via NEDD4/KLF15 axis

    Journal of Cachexia, Sarcopenia and Muscle, Vol. 12, Núm. 2, pp. 493-505

2018

  1. Erratum to: Obestatin controls skeletal muscle fiber-type determination (Scientific Reports, (2017), 7, 1, (2137), 10.1038/s41598-017-02337-4)

    Scientific Reports

  2. Improvement of Duchenne muscular dystrophy phenotype following obestatin treatment

    Journal of Cachexia, Sarcopenia and Muscle, Vol. 9, Núm. 6, pp. 1063-1078

2017

  1. Obestatin controls skeletal muscle fiber-type determination

    Scientific Reports, Vol. 7, Núm. 1

  2. Obestatin controls the ubiquitin–proteasome and autophagy–lysosome systems in glucocorticoid-induced muscle cell atrophy

    Journal of Cachexia, Sarcopenia and Muscle, Vol. 8, Núm. 6, pp. 974-990

2016

  1. β-Arrestin scaffolds and signaling elements essential for the obestatin/GPR39 system that determine the myogenic program in human myoblast cells

    Cellular and Molecular Life Sciences, Vol. 73, Núm. 3, pp. 617-635

2013

  1. β-Arrestin signal complex plays a critical role in adipose differentiation

    International Journal of Biochemistry and Cell Biology, Vol. 45, Núm. 7, pp. 1281-1292